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Statistical Removal of Background Signals from High-
throughput 1H NMR Line-broadening Ligand-affinity Screens
Bradley Worley, Nicholas J. Sisco, and Robert Powers*
Department of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588-0304
Abstract
NMR ligand-affinity screens are vital to drug discovery, are routinely used to screen fragment-
based libraries, and used to verify chemical leads from high-throughput assays and virtual screens. 
NMR ligand-affinity screens are also a highly informative first step towards identifying functional 
epitopes of unknown proteins, as well as elucidating the biochemical functions of protein-ligand 
interaction at their binding interfaces. While simple one-dimensional (1D) 1H NMR experiments 
are capable of indicating binding through a change in ligand line shape, they are plagued by broad, 
ill-defined background signals from protein 1H resonances. We present an uncomplicated method 
for subtraction of protein background in high-throughput ligand-based affinity screens, and show 
that its performance is maximized when phase-scatter correction (PSC) is applied prior to 
subtraction.
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INTRODUCTION
SAR by NMR (Shuker et al. 1996) spurred a revolution for the role of NMR in drug 
discovery. Like X-ray crystallography, NMR had been primarily used as a means to 
determine protein and protein-ligand structures as part of a structure-based drug discovery 
effort (Ferentz and Wagner 2000). NMR is now an important alternative to traditional high-
throughput assays (HTS) for identifying drug-like chemical leads (Pellecchia et al. 2002; 
Powers 2009). By combining NMR ligand-affinity screens with fragment-based libraries, a 
dramatic increase in chemical diversity is achieved (from 106 to 1063), while also 
minimizing resources, increasing hit-rates and improving the drug-like qualities of the 
resulting chemical leads (Baker 2013; Hajduk and Greer 2007). Consequently, NMR 
fragment-based screens have significantly benefited the pharmaceutical industry by leading 
to a number of clinical-stage compounds (Baker 2013).
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NMR ligand-affinity screening is also a powerful platform for protein functional annotation 
during the search for novel drug targets (Mercier et al. 2009; Powers et al. 2008). A 
significant percentage of the human proteome and the proteomes of other infectious 
organisms is comprised of functionally uncharacterized proteins (Muller et al. 2002). 
Undoubtedly hidden among this multitude of unannotated proteins are novel drug targets 
that may lead to new treatments or new means of overcoming mechanisms of drug 
resistance. Besides verifying that a functionally unannotated protein is druggable, NMR 
ligand affinity screening also identifies the functional epitope and the classes of ligands that 
bind the uncharacterized protein. This information may then be leveraged to infer a function 
through structural similarities with functionally annotated proteins (Powers et al. 2006; 
Powers et al. 2011).
NMR spectroscopy reports a multitude of time-averaged physical observables that carry 
information relating to the nature of interactions between small molecule ligands and protein 
targets (Lepre et al. 2004). A number of one-dimensional (1D) 1H NMR pulse sequences 
have been developed to probe these distinct features of binding, including differences in free 
and bound ligand diffusion and relaxation properties (Hajduk et al. 1997), and saturation 
transfers from water (Dalvit et al. 2000) and protein (Mayer and Meyer 2001) resonances. 
As part of an NMR high-throughput screen, these 1D 1H NMR pulse sequences present a 
number of unique challenges that include high false positive rates, low throughput, and high 
demand for protein samples (Harner et al. 2013; Lepre 2011). However, at suitably chosen 
concentrations of ligand and protein, a standard, unedited 1D 1H NMR experiment may be 
used to detect binding interactions through enhanced relaxation rates of ligand spins 
(Mercier et al. 2006; Mercier et al. 2009; Powers et al. 2008).
While it is possible to detect ligand binding using standard 1D 1H NMR, the resulting 
spectra are a combination of free and bound ligand and protein signals, a fact which makes 
them difficult to interpret. Broad, rolling baselines arising from slowly tumbling protein 
spins are particularly problematic during interpretation, as they often mask changes in ligand 
signal broadness and intensity. This masking effect due to protein baselines is exacerbated at 
protein-ligand concentration ratios nearing or exceeding unity, forcing the use of excess 
ligand during analysis and increasing the false negative rate during screening. To mitigate 
these issues, we present a statistical method, called Uncomplicated Statistical Spectral 
Remodeling (USSR), which removes protein baselines from high-throughput ligand-based 
screening datasets by leveraging inter-sample reproducibility of protein signals. In addition, 
we show that the use of phase-scatter correction (PSC) (Worley and Powers 2014b) greatly 
improves inter-sample protein baseline reproducibility and reduces the false-positive rate 
incurred by subsequent USSR-based analyses. Our reported combination of PSC and USSR 
enables a rapid analysis of standard 1D 1H NMR screening data, especially in difficult cases 
having a high protein-ligand concentration ratio.
MATERIALS AND METHODS
Sample preparation and NMR acquisition
A set of 117 samples containing free ligand mixtures and a set of 117 samples containing 
Bovine Serum Albumin (BSA) and ligand mixtures were prepared based on previously 
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published procedures (Mercier et al. 2009; Powers et al. 2008). In summary, each mixture 
contained no more than four ligands, each ligand had a concentration of 100 μM, and BSA 
had a concentration of 200 μM. All NMR samples were prepared to 600 μL total volume in a 
buffer containing 10 mM bis-tris-d19, 1 mM NaCl, 1 mM KCl, 1 mM MgCl2, and 10 μM 
TMSP in D2O at pH 7.0 (uncorrected). Samples were loaded into standard 5 mm NMR 
tubes for spectral acquisition.
All NMR experiments were collected on a Bruker Avance DRX 500 MHz spectrometer 
equipped with a 5 mm inverse triple-resonance (1H, 13C, 15N) cryoprobe with a z-axis 
gradient. A Bruker BACS-120 sample changer and ICON-NMR software were used to 
automate NMR data collection. Standard 1D 1H NMR spectra were collected for each 
sample using a SOGGY water suppression pulse sequence (Hwang and Shaka 1995; Nguyen 
et al. 2007). All experiments were performed at 20 °C with 256 scans, 8 dummy scans, a 
carrier frequency offset of 2352.1 Hz, a 5482.5 Hz spectral width, and a 1.0 s inter-scan 
delay. Free induction decays were collected with 4k complex data points resulting in a total 
acquisition time of 8 minutes per experiment.
NMR processing
Acquired NMR spectra were loaded and processed in batch inside the GNU Octave 3.6 
programming environment (Eaton et al. 2008) using functions available in the MVAPACK 
software package (Worley and Powers 2014a). Free induction decays were loaded in from 
Bruker DMX binary format and corrected for group delay errors by a circular shift. All 
decays were then zero filled twice, Fourier transformed and automatically phase corrected 
using a simplex optimization routine. Phase-scatter correction (Worley and Powers 2014b) 
was applied to a copy of the screen spectral data, and spectral remodeling was performed in 
parallel on the uncorrected and corrected datasets for the purposes of comparison.
Phase-scatter correction
The phase-scatter correction (PSC) algorithm is a spectral normalization method that 
includes zero-order and first-order phase correction terms in its objective function (Worley 
and Powers 2014b). As a normalization method, PSC scales each ‘target’ spectrum in a 
dataset to match a reference spectrum, which is usually the mean. Differences in relative 
phase between spectra, which confound the identification of ideal scaling values, are also 
corrected by PSC within a Levenberg-Marquardt nonlinear optimization of the following 
objective:
(1)
where sk and rk are the k-th data points of the K-element target and reference spectra, 
respectively. The PSC algorithm identifies an optimal scale factor (β) and phases (φ0, φ1) for 
each spectrum in the dataset, and returns the corrected data matrix after applying the 
identified scaling and phase correction to each spectrum.
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Statistical spectral remodeling
Our method of spectral remodeling (USSR) capitalizes on the reproducibility of the protein 
baseline and the low likelihood that ligand signals will dominate any given spectral data 
point across multiple samples. For each pair of free mixture (fi) and screen (mixture plus 
protein, pi) 1H NMR spectra, a difference spectrum (di) is computed using a simple point-
wise subtraction. The central tendency (μ) and dispersion (σ) of the difference spectra are 
then robustly estimated using the median and median absolute deviation, respectively. 
Figure 1 shows the statistical baseline computed by USSR from an analysis of ligand 
binding to BSA. Once a statistical baseline is established for a given dataset, each spectrum 
pi in the screen is remodeled to maximally remove interference from protein signals. Each 
spectral data point in pi is compared to μ ± σ using a Bonferroni-corrected Student’s t-test 
(Dunn 1961). The resulting p value provides a measure of how distinguishable the 
corresponding data point is from the statistical baseline. Based on a preselected level of 
significance (α), data points having low p values are retained (less the statistical baseline) in 
the remodeled spectrum (ri) and data points having high p values are modeled as Gaussian 
white noise. Figure 2 shows an example remodeled spectrum from the ligand binding 
analysis of BSA.
Statistical hit determination
For each peak in each remodeled spectrum from USSR, a KD was computed based on the 
intensity ratio between free and remodeled ligand signals. First, in the limit of fast exchange 
between free and bound ligand states relative to the NMR timescale, the fraction of bound 
ligand (fB) was computed:
(2)
where IF and IB are the intensities of free and remodeled (bound) ligand signals, and vF and 
vB are the estimated NMR line widths of the free and remodeled ligand signals, respectively 
(Shortridge et al. 2008). This fast-exchange assumption may be safely regarded as valid in 
most high-throughput 1D 1H NMR protein-ligand affinity screening experiments (Lepre et 
al. 2004), where the width and intensity of each ligand signal is a population-weighted sum 
of its values in the free and bound states. Without any assumptions about relative 
concentrations of ligand and protein, the fraction of bound ligand is related to total protein 
concentration [P]T, total ligand concentration [L]T and KD via the following equation 
(Shortridge et al. 2008):
(3)
Footnote, equation 3: The equation reported in the main text of Shortridge et al. 2008 
(equation 3) contains a typographical error. The correct equation (equation A8) may be 
found in the Appendix of the aforementioned work.
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The symbolic solution of the above equation for KD (Wolfram Research 2014) yields the 
following result:
(4)
which was then used to compute per-peak KD values for each remodeled spectrum ri. 
Finally, the per-peak KD values were used to compute sample mean and standard deviation 
KD values for each ligand. Hit detection was accomplished by comparing per-ligand mean 
and standard deviation KD values against a threshold via a Student’s t-test, where a resulting 
p value less than a predefined significant p value was reported as binding.
Analysis of dataset size
A small simulation study was performed to assess the quality of USSR statistical baseline 
estimates over a range of sample sizes (number of spectral pairs). For sizes from 2 to 116, 
the BSA dataset was randomly subsampled, without replacement, to produce a smaller 
dataset. For each resultant dataset, the statistical baseline was estimated, and its Pearson 
correlation to the true statistical baseline was computed and stored. Over all numbers of 
spectral pairs in the simulation, the median baseline correlations were computed, and are 
reported in Supplementary Figure S-1.
RESULTS
From the USSR analysis of ligand binding to BSA, 43 compounds were classified as hits 
from the library of 456 compounds. All classified hits were determined to bind BSA with at 
least 1.0 mM affinity at a statistical confidence level of 99%. A summary of the hits, along 
with their estimated KD and p values, is provided in Supplementary Table S-1. Comparison 
of results from both PSC-corrected and uncorrected USSR datasets reveals that the use of 
PSC normalization prior to USSR modeling greatly reduces the effective positive rate of 
statistical hit determination: 195 hits were identified from the PSC-uncorrected spectra. 
Closer examination of hits identified without PSC correction indicates that USSR failed to 
fully subtract the statistical baseline from the screen spectra (e.g. Figure S-2), resulting in 
residual baseline intensity passing into equation 2 during KD calculation and hit 
determination. In short, the use of PSC normalization prior to USSR enables more effective 
baseline subtraction by decreasing both dilution- and phase-related protein baseline intensity 
variation in collected 1H NMR spectra (Figure 3). Baseline estimates obtained by collecting 
a spectrum of pure protein will suffer from the same phase-induced variation, which would 
also increase the false positive rate during hit determination. Our introduced combination of 
PSC and USSR provides a more reliable means of baseline identification, without the 
collection of a free protein spectrum.
Our cursory analysis of the robustness of the USSR statistical baseline during random 
subsampling of the BSA dataset indicated that the PSC/USSR methodology can reliably 
operate at very low dataset sizes (i.e. 10–20 spectral pairs). Pearson correlations between 
true and subsampled baselines did not appreciably decrease even after harsh subsampling 
(Supplementary Figure S-1), and correlations computed from PSC-normalized data 
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maintained significantly higher values than those from non-normalized data. While it would 
be possible to obtain a statistical baseline from fewer than ten spectral pairs, this is not 
recommended, as it will decrease the effectiveness of the Bonferroni-corrected t-test that 
USSR performs during remodeling. Therefore, as a general rule of thumb, PSC/USSR 
analyses may be performed on high-throughput screening datasets having as few as ten 
spectral pairs, and higher sample sizes only serve to further increase the reliability of 
remodeled results.
DISCUSSION AND CONCLUSIONS
While the saturation transfer difference (STD) NMR experiment (Mayer and Meyer 2001) is 
a popular choice for ligand-based NMR affinity screens, a 1D 1H NMR line-broadening 
experiment is often a more efficient alternative. A standard 1D 1H NMR spectrum requires 
only a few seconds to acquire, making it an ideal choice for high-throughput screening. STD 
experiments require significantly longer acquisition times (upwards of hours) in order to 
acquire difference spectra with sufficient signal-to-noise to reduce false negatives. A 
particular strength of STD is the minimal amount of protein required per experiment, 
making it practical to screen a reasonably large chemical library (upwards of thousands of 
compounds) with only a few milligrams of protein. Through a judicious choice of protein 
and ligand concentrations coupled with the use of cryoprobes and high magnetic fields, it is 
also possible to minimize protein requirements in 1D 1H line-broadening screens. While 
STD experiments still tend to require less protein than line-broadening experiments, the 
higher false positive rate of STD screening easily negates any advantages of minimal protein 
usage. This high false positive rate arises due to the tendency of STD experiments to 
emphasize weak binding affinities commonly encountered during aggregation and 
nonspecific binding (Harner et al. 2013; Lepre 2011).
NMR line-broadening experiments take advantage of the molecular-weight dependence of 
T2 relaxation and the resultant measurable difference in line-widths between proteins and 
the compounds in a screening library (Hajduk et al. 1997). Upon binding a protein target, 
the 1H NMR resonances of a compound will broaden significantly or even disappear. In 
principal, this spectral broadening is easily observable and binding is readily identified. In 
practice, the background signals from the protein can confound the data analysis. This 
background interference increases with the size and concentration of the protein and leads to 
an increase in false negative rates. Apparent line-width differences between free and bound 
ligands also increase with protein size and concentration, making the optimal experimental 
conditions for NMR line-broadening screens exactly the same conditions which confound 
manual interpretation. Clearly, the ability to accurately remove the protein background from 
an NMR line-broadening experiment will improve both the utility and realability of the 
technique, especially at relatively high protein-ligand concentration ratios where binding is 
more apparent.
By removing interfering protein baseline signals, our Uncomplicated Statistical Spectral 
Remodeling (USSR) method for analyzing 1D 1H NMR line-broadening spectra for high-
throughput screening provides a straightforward means to visually or computationally 
analyze screening results. In fact, the outcome of applying our USSR method to an 
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extremely challenging and atypical test case is rather dramatic: our NMR line-broadening 
screen using BSA and a chemical library of 456 compounds identified 43 binders, despite 
the BSA background signals completely obscuring the ligand spectra. An example screening 
result of tolazamide, dimethyl 4-methoxyisophthalate, 1,7-dimethylxanthine and oxolinic 
acid against BSA is illustrated in Figure 2. Removal of the interfering protein statistical 
baseline from the screen spectrum (Figure 2B) yielded a high-quality pseudo-spectrum of 
the ligand mixture in the presence of BSA. Overlaying the remodeled NMR spectrum with 
the free ligand mixture spectrum indicated that the two spectra were essentially identical for 
the non-binding ligands (Figure 2A). Only dimethyl 4-methoxyisophthalate, which binds 
BSA, exhibited any difference after remodeling. The USSR method of baseline estimation 
and subtraction is expected to perform equally well under any conditions where a common, 
highly reproducible spectral feature exists within a dataset. Our application of PSC/USSR to 
high-throughput protein-ligand affinity screening is but one example of its potential uses.
However, reliable identification of the protein baseline from screening data requires highly 
reproducible sample preparation, data collection and processing. The last of these 
requirements is met by the use of phase-scatter correction (PSC) (Worley and Powers 
2014b) prior to remodeling, which brings protein baselines from all spectra into closer 
agreement with each other and minimizes the number of false hits identified during analysis. 
It is important to note that PSC is only an effective pre-treatment for USSR when protein 
baseline signals are of comparable intensity to ligand signals. PSC normalization is designed 
to maximize statistical agreements between spectra by phasing and normalization correction, 
and its use of the L2 norm as a criterion for ‘agreement’ implies that higher-intensity features 
will be preferentially corrected. Thus, PSC achieves the best results prior to USSR when 
protein signals are a major spectral component, as is the case when protein-ligand 
concentration ratios are near or greater than unity. In effect, the combined use of PSC and 
USSR expands the range of protein-ligand concentration ratios which may be probed by 1H 
line-broadening experiments for the purposes of high-throughput screening.
Finally, it cannot be under-emphasized that the single-point KD computations employed by 
USSR during statistical hit determination are only order-of-magnitude estimates of the true 
dissociation rates, and can carry significant systematic and random errors. In particular, the 
fraction of bound ligand – and by extension, the dissociation constant – depends exquisitely 
on the estimated free and bound ligand linewidths, vF and vB. Thus, any imprecision in the 
linewidth estimates will propagate into a systematic bias in the final dissociation constants. 
If required, verification of initial hits may be achieved to higher accuracy via multiple-point 
estimation of the KD through nonlinear least squares (Shortridge et al. 2008).
An implementation of the USSR algorithm is available in open-source GNU Octave code as 
a part of the MVAPACK toolbox, downloadable at http://bionmr.unl.edu/mvapack.php.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Statistical baseline (mean plus or minus four standard deviations) computed from the NMR 
ligand-based screen against BSA. The mean baseline is traced in deep red, while the 
baseline is filled in light red underneath.
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Figure 2. 
An example spectral remodeling result of tolazamide, dimethyl 4-methoxyisophthalate, 1,7-
dimethylxanthine and oxolinic acid in the presence of BSA, showing (A) the free ligand 
spectrum (black) and the remodeled spectrum (red) resulting from removing the statistical 
baseline (red) from the screen spectrum (black) in (B). The remodeled pseudo-spectrum 
readily indicates that several peaks from dimethyl 4-methoxyisophthalate have broadened 
into the baseline due to interaction with BSA.
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Figure 3. 
Relative standard deviations (RSDs) of the statistical baselines computed before (red) and 
after (black) phase-scatter correction, which substantially decreases inter-sample variability 
of the protein baseline signals.
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